Advent Pharma Limited announced earnings results for the first quarter ended September 30, 2019. For the first quarter, the company announced sales was BDT 172.464 million compared to BDT 155.479 million a year ago. Operating income was BDT 69.267 million compared to BDT 59.997 million a year ago. Net income was BDT 52.448 million compared to BDT 41.630 million a year ago. Basic earnings per share was BDT 0.7 compared to BDT 0.61 a year ago.